Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

The opium poppy (Papaver somniferum) has a weird double life. The plant’s seeds give a tasty, nutty flavor to bagels, breads, ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

The high-profile semaglutide drugs Ozempic and Wegovy have changed how millions of adults manage type 2 diabetes and weight, respectively. Now many thousands of teenagers are being prescribed ...

Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results land all over the map.

With the ease of online publishing, the number of journals has exploded, and with them the number of papers. It has gotten ...

In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that targets four gut hormones instead of the usual one to three. These next-gen ...

Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...